A group of US House Democrats and the left-leaning Center for American Progress have issued statements ahead of President Trump’s May 11 speech on drug pricing expressing concern the Administration’s plans for lowering drug pricing may not go far enough.
The Center for American Progress cited the recent revelations about Novartis’ payments to Trump’s attorney Michael Cohen as fuel for its skepticism that the Administration will get tough
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?